Neoadjuvant Chemotherapy for the Treatment of Resectable Locally Advanced Colon Cancer

NCT02882269 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Colon Cancer

Interventions

DRUG: Postoperative chemotherapy
DRUG: Neoadjuvant chemotherapy

Sponsor

The First Affiliated Hospital with Nanjing Medical University